Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value: $569M (100.0% shares, 0.0% debt)

Holdings (31)

— LOXO ONCOLOGY INC 7.3%

Value $41.53M Shares 360,000 Est. Cost $28.44 Unrealized —

— FOUNDATION MEDICINE INC 7.2%

Value $40.95M Shares 520,000 Est. Cost $22.74 Unrealized —

— SAGE THERAPEUTICS INC 7.1%

Value $40.27M Shares 250,000 Est. Cost $52.53 Unrealized —

— BLUEPRINT MEDICINES CORP 5.6%

Value $31.91M Shares 348,000 Est. Cost $37.87 Unrealized —

— SPARK THERAPEUTICS INC 5.4%

Value $30.83M Shares 463,000 Est. Cost $58.74 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 5.2%

Value $29.83M Shares 364,776 Est. Cost $57.83 Unrealized +33.7%

ALNY ALNYLAM PHARMACEUTICALS INC 5.2%

Value $29.77M Shares 250,000 Est. Cost $84.46 Unrealized +52.6%

— GLOBAL BLOOD THERAPEUTICS IN 5.1%

Value $28.98M Shares 600,000 Est. Cost $32.45 Unrealized —

— MYOKARDIA INC 4.8%

Value $27.33M Shares 560,000 Est. Cost $22.11 Unrealized —

SGMO SANGAMO THERAPEUTICS INC 4.7%

Value $26.6M Shares 1,400,000 Est. Cost $4.96 Unrealized +331.4%

FATE FATE THERAPEUTICS INC 4.5%

Value $25.38M Shares 2,600,000 Est. Cost $4.33 Unrealized +121.3%

— BLUEBIRD BIO INC 4.4%

Value $24.76M Shares 145,000 Est. Cost $115.06 Unrealized —

CDXS CODEXIS INC 3.9%

Value $22.27M Shares 2,025,000 Est. Cost $5.90 Unrealized +62.2%

VYGR VOYAGER THERAPEUTICS INC 3.8%

Value $21.33M Shares 1,135,000 Est. Cost $14.86 Unrealized —

— GENMARK DIAGNOSTICS INC 3.7%

Value $20.94M Shares 3,850,000 Est. Cost $6.84 Unrealized —

ILMN ILLUMINA INC 3.0%

Value $16.9M Shares 71,500 Est. Cost $196.93 Unrealized +16.4%

EVH EVOLENT HEALTH INC 2.8%

Value $15.82M Shares 1,110,000 Est. Cost $17.59 Unrealized -18.6%

— JOUNCE THERAPEUTICS INC 2.5%

Value $14.19M Shares 635,000 Est. Cost $18.19 Unrealized —

— AUDENTES THERAPEUTICS INC 2.4%

Value $13.52M Shares 450,000 Est. Cost $19.14 Unrealized —

ONC BEIGENE LTD 2.1%

Value $11.76M Shares 70,000 Est. Cost $149.93 Unrealized —

IBB ISHARES TR 1.8%

Value $10.14M Shares 95,000 Est. Cost $106.74 Unrealized —

— CLOVIS ONCOLOGY INC 1.6%

Value $9.372M Shares 177,500 Est. Cost $78.32 Unrealized —

CRSP CRISPR THERAPEUTICS AG 1.1%

Value $6.171M Shares 135,000 Est. Cost $41.27 Unrealized 0.0%

CTMX CYTOMX THERAPEUTICS INC 1.0%

Value $5.903M Shares 207,500 Est. Cost $17.02 Unrealized +67.7%

EDIT EDITAS MEDICINE INC 0.8%

Value $4.42M Shares 133,333 Est. Cost $20.61 Unrealized +72.9%

NEOG NEOGEN CORP 0.8%

Value $4.354M Shares 65,000 Est. Cost $30.13 Unrealized 0.0%

OSUR ORASURE TECHNOLOGIES INC 0.7%

Value $4.054M Shares 240,000 Est. Cost $18.96 Unrealized 0.0%

— CELGENE CORP 0.6%

Value $3.568M Shares 40,000 Est. Cost — Unrealized —

ZLAB ZAI LAB LTD 0.5%

Value $2.882M Shares 135,000 Est. Cost $21.35 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 0.3%

Value $1.74M Shares 300,000 Est. Cost $5.80 Unrealized —

— HOMOLOGY MEDICINES INC 0.2%

Value $1.122M Shares 60,000 Est. Cost $18.70 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	LOXO ONCOLOGY INC	360,000	$41.53M	7.3%	$28.44	—	COM	548862101
—	FOUNDATION MEDICINE INC	520,000	$40.95M	7.2%	$22.74	—	COM	350465100
—	SAGE THERAPEUTICS INC	250,000	$40.27M	7.1%	$52.53	—	COM	78667J108
—	BLUEPRINT MEDICINES CORP	348,000	$31.91M	5.6%	$37.87	—	COM	09627Y109
—	SPARK THERAPEUTICS INC	463,000	$30.83M	5.4%	$58.74	—	COM	84652J103
AGIO	AGIOS PHARMACEUTICALS INC	364,776	$29.83M	5.2%	$57.83	+33.7%	COM	00847X104
ALNY	ALNYLAM PHARMACEUTICALS INC	250,000	$29.77M	5.2%	$84.46	+52.6%	COM	02043Q107
—	GLOBAL BLOOD THERAPEUTICS IN	600,000	$28.98M	5.1%	$32.45	—	COM	37890U108
—	MYOKARDIA INC	560,000	$27.33M	4.8%	$22.11	—	COM	62857M105
SGMO	SANGAMO THERAPEUTICS INC	1,400,000	$26.6M	4.7%	$4.96	+331.4%	COM	800677106
FATE	FATE THERAPEUTICS INC	2,600,000	$25.38M	4.5%	$4.33	+121.3%	COM	31189P102
—	BLUEBIRD BIO INC	145,000	$24.76M	4.4%	$115.06	—	COM	09609G100
CDXS	CODEXIS INC	2,025,000	$22.27M	3.9%	$5.90	+62.2%	COM	192005106
VYGR	VOYAGER THERAPEUTICS INC	1,135,000	$21.33M	3.8%	$14.86	—	COM	92915B106
—	GENMARK DIAGNOSTICS INC	3,850,000	$20.94M	3.7%	$6.84	—	COM	372309104
ILMN	ILLUMINA INC	71,500	$16.9M	3.0%	$196.93	+16.4%	COM	452327109
EVH	EVOLENT HEALTH INC	1,110,000	$15.82M	2.8%	$17.59	-18.6%	CL A	30050B101
—	JOUNCE THERAPEUTICS INC	635,000	$14.19M	2.5%	$18.19	—	COM	481116101
—	AUDENTES THERAPEUTICS INC	450,000	$13.52M	2.4%	$19.14	—	COM	05070R104
ONC	BEIGENE LTD	70,000	$11.76M	2.1%	$149.93	—	SPONSORED ADR	07725L102
IBB	ISHARES TR	95,000	$10.14M	1.8%	$106.74	—	NASDAQ BIOTECH	464287556
—	CLOVIS ONCOLOGY INC	177,500	$9.372M	1.6%	$78.32	—	COM	189464100
CRSP	CRISPR THERAPEUTICS AG	135,000	$6.171M	1.1%	$41.27	0.0%	NAMEN AKT	H17182108
CTMX	CYTOMX THERAPEUTICS INC	207,500	$5.903M	1.0%	$17.02	+67.7%	COM	23284F105
EDIT	EDITAS MEDICINE INC	133,333	$4.42M	0.8%	$20.61	+72.9%	COM	28106W103
NEOG	NEOGEN CORP	65,000	$4.354M	0.8%	$30.13	0.0%	COM	640491106
OSUR	ORASURE TECHNOLOGIES INC	240,000	$4.054M	0.7%	$18.96	0.0%	COM	68554V108
—	CELGENE CORP	40,000	$3.568M	0.6%	—	—	Call	151020104
ZLAB	ZAI LAB LTD	135,000	$2.882M	0.5%	$21.35	—	ADR	98887Q104
—	ADVERUM BIOTECHNOLOGIES INC	300,000	$1.74M	0.3%	$5.80	—	COM	00773U108
—	HOMOLOGY MEDICINES INC	60,000	$1.122M	0.2%	$18.70	—	COM	438083107